Advanced Therapies Integrates

In collaboration with the Cell and Gene Therapy Catapult

Focused on bringing together industry leaders to help drive and deliver the full potential of Advanced Therapies and Medical Products (ATMPs). Specific themes and objectives will cover deployment of the key innovations and debating challenges facing the industry, including the regulatory and commercial barriers to effectively deploy such broad transformational changes.

Life Science Integrates is delighted to announce their first ever in-person Advanced Therapies Integrates conference, being held at the Leonardo Royal Hotel, London Tower Bridge.

It will engage across a broad network from pharma innovators, regulators, supply chain partners, equipment & technology providers, academia, industry associations, together with a wide array of government funding bodies and government supported pharma-focused initiatives.

This year the three sectors covered will be:

·         Cellular Growth – How do you secure VC investment? This track focuses on how to develop and present your advanced therapy innovation to secure investment

·         Tech to translate - Discover the scientific and technological innovations to support your ATMP getting to market

·         Making it - Discover how to manufacture your ATMPs, outsourced or in-house, and the process and analytical technology innovation that underpins success

For more information and to view the agenda please go to https://www.lifescienceintegrates.com/agenda/advanced-therapies-integrates-2022/

As SBC is a partner of Advanced Therapies Integrates 2022, we have a number of passes available for you to attend.

If you are a supplier to the life science industry (e.g. professional services, CMDOs, CROs, etc.) you can access a 25% discount by clicking here and using promo code ATI22SBC25.

We are able to offer complimentary passes to everyone else that would like to attend. To register please click here using promo code ATI22SBC100.

Please note registration closes at 17:00 on 10 October 2022.